| 
 | |||||
|   | 
| 
 | 

Engineered materials manufacturer Rogers (NYSE:ROG) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 2.7% year on year to $216 million. Guidance for next quarter’s revenue was better than expected at $197.5 million at the midpoint, 1.3% above analysts’ estimates. Its non-GAAP profit of $0.90 per share was 29.8% above analysts’ consensus estimates.
Is now the time to buy ROG? Find out in our full research report (it’s free for active Edge members).
Rogers’ third quarter results were positively received by the market, driven by broad-based sales growth across major end markets and improvements in operational efficiency. Management highlighted that portable electronics, industrial, aerospace, and defense sectors all contributed to the sequential sales increase, while cost and expense reduction actions supported margin expansion. Interim President and CEO Ali El-Haj noted, “Q3 results benefited from delivering on cost and expense reduction actions,” as the company executed on its plan to enhance competitiveness through customer focus and operational discipline. These factors contributed to Rogers’ outperformance relative to Wall Street’s expectations.
Looking ahead, Rogers’ guidance reflects confidence in continued top-line growth and margin improvement, underpinned by new product introductions and a renewed emphasis on customer alignment. Management pointed to the expansion of localized manufacturing in China, ongoing restructuring efforts in Germany, and a leaner cost structure as central to future performance. CFO Laura Russell cautioned that while ramping the new curamik facility in China will pose a short-term margin headwind, these investments are expected to support long-term competitiveness, stating, “We are positioned to compete effectively.” The company’s strategy centers on capturing new market share, optimizing its operational footprint, and accelerating product development to meet evolving customer needs.
Management attributed the quarter’s results to volume gains in key end markets, expense reductions, and initial benefits from operational changes, while highlighting new manufacturing capacity and product launches as growth enablers.
Rogers’ outlook is shaped by efforts to expand manufacturing capacity, control costs, and accelerate product innovation, while navigating end-market uncertainties and the ramp of new facilities.
In the quarters ahead, the StockStory team will be monitoring (1) the pace at which customers qualify and scale production at the new curamik facility in China, (2) the realization of cost savings from German restructuring and other operational initiatives, and (3) the commercial impact of upcoming product launches in new and existing end markets. We will also track management’s ability to sustain working capital improvements and further optimize the company’s manufacturing footprint.
Rogers currently trades at $85.21, up from $83.16 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free for active Edge members).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-28 | |
| Oct-27 | |
| Oct-16 | |
| Oct-15 | |
| Oct-13 | |
| Oct-08 | |
| Oct-06 | |
| Sep-23 | 
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite